补体C3与糖尿病发病率相关,但无证据表明存在因果关系
研究基于马尔默饮食与癌症研究队列中4368名46至68岁非糖尿病受试者,分析血浆补体因子3(C3)与17.7±4.4年随访期间糖尿病发病率的关系,并利用全基因组关联研究探索遗传变异。结果显示高C3与糖尿病发病率显著相关(第四分位 vs 第一分位风险比1.54,95%CI 1.13-2.09,P=0.005),C3与补体因子H位点多态性相关(P<10^-8),但该位点与糖尿病无关;GCKR位点与C3相关且既往与糖尿病相关,提示C3与糖尿病的关联可能部分由GCKR基因的多效性解释。
要点
- 高血浆C3与糖尿病发病率显著相关,风险比1.54(95%CI 1.13-2.09,P=0.005)。
- C3与补体因子H位点多态性相关(P<10^-8),但该位点与糖尿病无关。
- GCKR位点与C3相关且既往与糖尿病相关,关联可能部分由该基因多效性解释。
核心结论
- 血浆C3浓度是糖尿病发病的风险标志物,该关联可能部分由GCKR基因相关的多效性效应解释。
研究设计与样本
- 基于马尔默饮食与癌症研究人群队列,分析4368名46至68岁非糖尿病受试者的血浆C3,随访17.7±4.4年观察糖尿病发病率。
- 利用全基因组关联研究识别与C3相关的遗传变异,并使用糖尿病遗传学复制与荟萃分析及欧洲遗传数据库进行计算机查找。
主要发现
- 随访18年期间,共538名(12.3%)受试者发生糖尿病。
- 风险因素调整后,高C3与糖尿病发病率显著相关(第四分位 vs 第一分位风险比1.54,95%CI 1.13-2.09,P=0.005)。
- C3与补体因子H位点多态性相关(P<10^-8),但该位点与糖尿病无关联。
- 另发现八个位点与C3相关(P<10^-5),其中葡萄糖激酶调节蛋白(GCKR)位点既往与糖尿病相关,且C3与GCKR位点的关联在欧洲遗传数据库队列中重复验证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study explored whether complement factor 3 (C3) in plasma is associated with incidence of diabetes in a population-based cohort. We also identified genetic variants related to C3 and explored whether C3 and diabetes share common genetic determinants. METHODS: C3 was analyzed in plasma from 4368 nondiabetic subjects, 46 to 68 years old, from the Malmö Diet and Cancer Study. Incidence of diabetes was studied in relationship to C3 levels during 17.7± 4.4 years of follow-up. Genotypes associated with C3 were identified in a genome-wide association study. Diabetes Genetics Replication and Meta-Analysis and the European Genetic Database were used for in silico look-up. RESULTS: In all, 538 (12.3%) subjects developed diabetes during 18 years of follow-up. High C3 was significantly associated with incidence of diabetes after risk factor adjustments (hazard ratio comparing 4th vs 1st quartile, 1.54 (95% confidence interval, 1.13 to 2.09; P = 0.005). C3 was associated with polymorphisms at the complement factor H locus (P < 10-8). However, no relationship with diabetes was observed for this locus. Another eight loci were associated with C3 with P < 10-5. One of them, the glucose kinase regulatory protein (GCKR) locus, has been previously associated with diabetes. The relationship between C3 levels and the GCKR locus was replicated in the European Genetic Database cohort. CONCLUSIONS: Plasma concentration of C3 is a risk marker for incidence of diabetes. The results suggest that this association could, in part, be explained by pleiotropic effects related to the GCKR gene.
引用
- Borné Y, Muhammad IF, Lorés-Motta L, et al. Complement C3 Associates With Incidence of Diabetes, but No Evidence of a Causal Relationship. J Clin Endocrinol Metab. 2017. PMID: 29029276. doi:10.1210/jc.2017-00948
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。